| Rx for Wellness: Henry Ford West Bloomfield Hospital Opens
Patients will have access to the latest in technology, including robotic surgery for prostate cancer, the most accurate non-invasive treatment for cancer called Novalis Tx - the only one in the country - and imaging technology that includes MRI, PET and CT scanning for real-time visualization of the patient's condition. Some of the hospital's other special clinical care features are: Private ER exam rooms: The expanded emergency department includes 30 private exam rooms, about half of which have a private bathroom. The ER bays were designed to offer auditory and visual privacy for patients and their families. One-stop care for seniors: The Senior Center at the Neuroscience Institute offers older adults the opportunity to meet with physicians from up to nine clinical specialties - all during one appointment - to help rapidly diagnose and create a treatment plan for some of the most common and complicated disorders that affect the elderly, including cognitive, memory, balance and pain issues.
Allium Group receives CE Mark for next-generation prostatic stent
Allium's Prostatic Stents, used in patients with benign prostatic hyperplasia (BPH) or with advanced prostate cancer, have a triangular cross-section to match the contours of the prostatic urethral lumen and have the ability to exert varying degrees of radial force depending on the anatomy and function of this part of the male urethra. For example, higher radial force in its main body and lower radial force in the area near the external sphincter to prevent sphincteric dysfunction causing incontinence. These characteristics enable the Allium Prostatic Stents to conform to the prostatic urethral shape and function and offer a much improved comfort than existing stents in the long term. "Today the leading treatment options for BPH demand continuous treatment pharmacological or surgical interventions which become expensive and uncomfortable.
Pancreatic cancer difficult to detect, harder to treat
Complicating matters, people with pancreatic cancer usually have few, if any, symptoms until the disease is more advanced. In some cases, weight loss, abdominal or back discomfort, a slight yellowing of the eyes and skin and other complaints may alert doctors to the condition, but early warning symptoms are not common. .
Still waiting for cancer care
��We�re confident that he will also move ahead with the rapid-access clinics for prostate cancer and lung cancer within the coming 18 months.�
Plans to expand radiation therapy services around the country are also continuing, but it is unclear how the economic recession will affect the rollout of these expensive and labour-intensive services. Within the next week or two, the Health Service Executive hopes to �go live� with the new hospital consultants� contract, which will involve hospital doctors in multidisciplinary teams and clinical audits.
At a press briefing on the implementation of recommendations of the Commission on Public Safety last Thursday, Harney predicted that, alongside the reconfiguration of hospital services, a new era of patient safety and accountability was beginning.
The Apollo Hospitals Group in India has introduced a robot
Now patients in Bahrain and across the Middle East can access this advanced technology as India is a few hours away from the region.
While talking over this new technology, Dr. Prathap C. Reddy, Executive Chairman, Apollo Hospitals Group, said, �In our continuing endeavor to fight cancer, we have brought the most advanced CyberKnife in Asia Pacific. It is the world�s first and only robotic radiosurgery system designed to treat tumors anywhere in the body with sub-millimeter accuracy. Undoubtedly the next frontier in cancer treatment.�
Dr. John.R.Adler, MD, professor of Neurosurgery and Radiation Oncology at Stanford University Medical Centre, has developed the machine.
Sanjay Chandrasekar, senior consultant, radiation oncology said that the biggest advantage is that the cyberknife treatment procedure can be completed in a week's time, which is far less than that of the conventional cancer therapies.
Weight loss may be a sign of cancer
Gradual weight loss may be a symptom of cancer, particularly in colon, kidney and lung cancer, Germany's cancer society has found. As tumours grow, they deprive the body of so much nutrition that weight loss results, said Eva Kalbheim, a spokeswoman for the cancer society. She therefore recommends regular preventative check-ups. And people who lose weight without trying or without changing their lifestyle should see a doctor quickly. "Other unspecific symptoms provide important clues: Back pain points to a kidney problem, while coughing in the morning indicates a problem in the lungs," Kalbheim said. Blood tests and ultrasound provide further insight. But all too often weight loss is not taken seriously. Who wouldn't be happy over the loss of a few kilograms without having been on a strenuous diet.
Is your home making you sick?
Animal and human studies have linked chemical phthalates found in plastic toys to a broad range of health problems, including prostate and breast cancer, and altered genital development. While some argue against these findings, most child safety advocates tell parents to avoid using any soft plastic mouthing objects (teethers, sippy cups, pacifiers, etc.) unless they are clearly marked PVC-free or phthalate-free.
Keep it hot
That hamburger may look delicious. But meat can be hazardous to your health. E. coli is a germ that thrives in undercooked meat, causing severe illness and in some cases, death. Best defense? Always scour cutting boards with soap and water, wash your hands before and after food preparation, keep children away from any raw meat, and make sure that any meat you eat is thoroughly cooked at the center.
Pulse investigation: new health centres are GP led in name only
Three trusts also revealed that new clinics would be offering Zoladex hormone injection treatment for prostate and breast cancer. ‘We are very excited by it [the new centre] because we think it will be quite a step change in local provision,' says Dr Yates. Just how GP-led health centres will develop will become clearer over the coming months, as over 100 of the centres open up across the country. Alan Johnson recently hailed the first of the centres to open, in Bradford, as a blueprint for the future of general practice. If we are looking at a vision of the future, it is one dominated by extended opening, walk-in access, an integration between health and social care – and a workforce of nurses and salaried doctors. General practice may never be the same again.
'I Practise What I Preach ..i Had To Get Involved'
The Beatson Translational Research Centre is set to become the first laboratory in Scotland dedicated to turning scientific discoveries into cancer treatments. It is Kirsty's job to manage the staff who organise the events programme. She also recruits and trains volunteers who offer their assistance to the appeal. The £1K Challenge was launched recently by television presenter Shereen Nanjiani. Farmer's wife Kirsty, who is based at Glasgow University, has signed up to give a regular gift under the appeal, which lets her see her donations build up from month to month like a mound of pebbles. She said: "We are on the lookout for people to get involved in the campaign, whether it's taking part in the £1K Challenge or at one of our appeal events." The Beatson Translational Research Centre will be built at Garscube Estate in Bearsden, Glasgow, and will focus on a range of cancers that are common in Scotland such as breast, prostate, ovarian, lung, throat, mouth, stomach and gastro intestinal.
Concerned about Prostate Cancer? New Drug May Help Prevent the Disease
Healthy men who are worried about prostate cancer should consider taking a drug called finasteride daily to reduce their risk of developing the condition. Finasteride is sold by Merck as Proscar to treat swollen prostates and as Propecia to treat baldness. The recommendation especially applies for men with a normal reading on the prostate-specific antigen or PSA, test, which is considered the best indicator of the presence of a tumor. Clinical trials on the drug included only men in this category. Previous studies have also shown that the drug reduces the risk of prostate cancer, but experts are worried that it may be responsible for an increased risk of deadliest tumors. Recent analysis, however, have dismissed these worries and the American Society of Clinical Oncology and the American Urological Association recommend patients to talk to their doctor about the benefits of this drug.
|
